Evofem Biosciences (EVFM) Change in Receivables (2020 - 2026)
Evofem Biosciences' Change in Receivables came in at $1.94 million for Q2 2026, down 48.8% from $3.79 million a year earlier.
Powered by 
Analysis
Evofem Biosciences (EVFM) Change in Receivables (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Evofem Biosciences reported Change in Receivables of -$2.44 million; for FY2025, it came in at $2.65 million, down 35.3% from FY2024.
- Change in Receivables carries a five-year compound annual growth rate of 19.9% (FY2020 to FY2025).
- Going back by year, Change in Receivables was $4.09 million in FY2024 (-11.2%), $4.61 million in FY2023, -$5.32 million in FY2022 and $5.38 million in FY2021 (+404.4%).
- The five-year range for quarterly Change in Receivables is -$11.92 million (Q1 2026) to $8.05 million (Q4 2025).
- Business Quant data shows EVFM's Change in Receivables at -$11.92 million (Q1 2026), $8.05 million (Q4 2025) and -$499,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Evofem Biosciences | 824,026.65 | 824,026.65 | 2.12 Mn | 1.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | -11.92 Mn |
| Dec 31, 2025 | 8.05 Mn |
| Sep 30, 2025 | -499,000.00 |
| Jun 30, 2025 | 3.79 Mn |
| Mar 31, 2025 | -8.68 Mn |
| Dec 31, 2024 | 4.44 Mn |
| Sep 30, 2024 | 776,000.00 |
| Jun 30, 2024 | 311,000.00 |
| Mar 31, 2024 | -1.43 Mn |
| Dec 31, 2023 | -584,000.00 |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | -2.21 Mn |
| Mar 31, 2023 | 6.28 Mn |
| Dec 31, 2022 | -11.64 Mn |
| Sep 30, 2022 | 5.46 Mn |
| Jun 30, 2022 | 2.89 Mn |
| Mar 31, 2022 | -2.03 Mn |
| Dec 31, 2021 | 2.42 Mn |
| Sep 30, 2021 | 923,000.00 |
API Access
Evofem Biosciences Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();